Analyst Price Target is $29.67
▲ +22.19% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Caribou Biosciences in the last 3 months. The average price target is $29.67, with a high forecast of $32.00 and a low forecast of $27.00. The average price target represents a 22.19% upside from the last price of $24.28.
Current Consensus is
The current consensus among 3 polled investment analysts is to buy stock in Caribou Biosciences.